Jacobi Capital Management LLC Sarepta Therapeutics, Inc. Transaction History

Jacobi Capital Management LLC

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$77.28 - $99.42 $53,323 - $68,599	-690 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$65.97 - $92.48 $3,958 - $5,548	60 Added 9.52%	690 $64,000
Q2 2021 Aug 12, 2021	SELL	$69.38 - $86.75 $10,407 - $13,012	-150 Reduced 19.23%	630 $49,000
Q1 2021 May 11, 2021	BUY	$72.25 - $168.95 $19,796 - $46,292	274 Added 54.15%	780 $58,000
Q3 2020 Oct 30, 2020	SELL	$127.12 - $172.34 $25,424 - $34,468	-200 Reduced 28.33%	506 $71,000
Q2 2020 Aug 04, 2020	SELL	$93.0 - $171.7 $467,604 - $863,307	-5,028 Reduced 87.69%	706 $113,000
Q2 2020 Jul 27, 2020	BUY	$93.0 - $171.7 $467,604 - $863,307	5,028 Added 712.18%	5,734 $113,000
Q1 2020 Apr 24, 2020	BUY	$82.38 - $131.64 $494 - $789	6 Added 0.86%	706 $69,000
Q4 2019 Feb 03, 2020	BUY	$76.53 - $135.58 $38,265 - $67,790	500 Added 250.0%	700 $90,000
Q4 2018 Feb 11, 2019	SELL	$97.32 - $148.76 $29,195 - $44,628	-300 Reduced 60.0%	200 $22,000
Q2 2018 Aug 14, 2018	BUY	$71.74 - $153.69 $35,870 - $76,845	500 New	500 $66,000

561

85.5M

3.67M

1.75M

Ticker SRPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 87,567,904
Market Cap $10.9B
Description
Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...

Get notified when there are updates to the investment portfolio of Jacobi Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Jacobi Capital Management LLC with notifications on news.